医学
心肌梗塞
生物标志物
肌钙蛋白
利钠肽
危险分层
重症监护医学
内科学
心脏病学
心肌梗死诊断
诊断生物标志物
心力衰竭
诊断准确性
生物化学
化学
作者
Yuqi Chen,Yifei Tao,Lan Zhang,Weiting Xu,Xiang Zhou
标识
DOI:10.1136/postgradmedj-2019-136409
摘要
Abstract The incidence of acute myocardial infarction (AMI) has been increasing rapidly in recent years, seriously endangering human health. Cardiac biomarkers play critical roles in the diagnosis and prognosis of AMI. Troponin is a highly sensitive and specific biomarker for AMI diagnosis and can independently predict adverse cardiac events. Other biomarkers such as N-terminal B-type natriuretic peptide and C reactive protein are also valuable predictors of cardiovascular prognosis. Recently, several novel biomarkers have been identified for the diagnosis and risk assessment in patients with AMI. A multibiomarker approach can potentially enhance the diagnostic accuracy and provide more information for the early risk stratification of AMI. In this review, we will summarise the biomarkers discovered in recent years and focus on their diagnostic and prognostic value for patients with AMI.
科研通智能强力驱动
Strongly Powered by AbleSci AI